AI safety company Anthropic has reportedly acquired biotech AI startup Coefficient Bio for $400 million in stock.
Why it matters
This acquisition highlights the growing trend of major AI companies diversifying their applications and investing in specialized AI startups. Anthropic's move into biotech suggests a strategic effort to apply advanced AI capabilities to biological research and development, potentially accelerating drug discovery or other life sciences innovations. It also underscores the significant financial valuations being placed on AI companies with specific domain expertise.
A big AI company called Anthropic is buying a smaller AI company that works with biology. This means Anthropic wants to use its AI skills to help with things like medicine and health.
Moonbounce, an AI content moderation startup, has secured $12 million in funding to enhance its AI control engine, which translates content moderation policies into consistent AI behavior.
Read on TechCrunch →ElevenLabs has launched ElevenMusic, an AI-powered music generation app that allows users to create and remix songs using text prompts.
Read on TechCrunch →Troubled YC startup Delve faces new allegations of violating open-source licenses by repurposing customer code.
Read on TechCrunch →